SARS-CoV-2 ORF8 Peptide (RCSFYEDFLEYHDVR)
Coronavirus Peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Sequence | RCSFYEDFLEYHDVR |
---|---|
Purity | >90% (HPLC-MS) |
Application ![]()
| Cellular immune response, T-cell expansion, Antigen specific T-cell stimulation, Immune monitoring, T-cell assays |
Primary Accession | P0DTC8 |
Gene ID | 43740577 |
---|---|
Other Names | ORF8 protein, Non-structural protein 8, ns8, nsp8 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | 8 |
---|---|
Function | ORF8 protein of SARS-CoV-2 is thought to play a role in host-virus interaction, although the exact mechanisms hve not been well-defined. The motif VLVVLhas been found in SARS-CoV ORF8b which was appeared to trigger intracellular stress pathways and enact NOD-like receptor family pyrin region containing-3 (NLRP3) . Thusly, it will be critical to examine the biological function of ORF8 in SARS-CoV-2. |
Cellular Location | Host Cytoplasm, host endoplasmic reticulum |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The M protein is a transmembrane glycoprotein composed of a triple membrane domain spanning 80 amino acids accounting for about one-third of the entire protein (221 residues in total). The most abundant structural protein in the SARS-CoV virion, M plays a a sigificante role in the viral budding process, as well as the virus-specific humoral response, indicated by its ability to elicit efficient neutralizing antibodies in SARS patients. It has therefore been proposed that the M protein is a good candidate antigen for a prophylactic vaccine inducing both dominant cellular and humoral immunogenicity.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.